MILabs

Freek Beekman is the CEO of MILabs. To contact Freek Beekman email at [email protected] or [email protected]. Or you may call +31.887565343

The decision makers in MILabs are Chao Wu, Chao Wu, Frank Schwahn, etc. Click to Find MILabs decision makers emails.

MILabs provides a range of high-performance imaging systems designed for preclinical research, including standalone and integrated systems for SPECT, PET, CT, and Optical Imaging. Our 4x4D multimodal imaging technology allows researchers to conduct comprehensive studies by combining different imaging modalities, enhancing the depth and quality of their molecular imaging and in vivo imaging research.

MILabs' imaging solutions play a crucial role in drug discovery by enabling researchers to visualize and quantify biological processes in real-time. Our advanced imaging technologies, such as PET and SPECT, allow for the monitoring of drug distribution, efficacy, and pharmacokinetics in small animal models, facilitating the optimization of drug candidates and accelerating the overall drug development process.

MILabs' imaging technologies are primarily utilized in the biomedical research industry, particularly in academic institutions, pharmaceutical companies, and biotechnology firms. Our systems are essential for researchers involved in molecular imaging, theranostics, and preclinical studies, providing them with the tools needed to advance their research in areas such as oncology, neurology, and cardiovascular diseases.

Multimodal imaging combines different imaging techniques to provide a more comprehensive view of biological processes. MILabs' 4x4D multimodal imaging technology allows researchers to gather complementary information from various imaging modalities, such as PET, SPECT, and CT, in a single experiment. This integration enhances the accuracy of data interpretation, leading to better insights into disease mechanisms and treatment responses.

Yes, MILabs' imaging systems are designed to accommodate both in vivo and ex vivo imaging applications. Our technologies enable researchers to perform real-time imaging of living organisms as well as post-mortem analysis of tissues and organs. This versatility supports a wide range of research applications, from studying dynamic biological processes in live animals to detailed investigations of specific tissues after imaging.

MILabs is committed to ensuring that users can effectively utilize our imaging systems. We offer comprehensive training programs that cover system operation, data acquisition, and analysis techniques. Additionally, our technical support team is available to assist users with any questions or issues that may arise, ensuring a smooth integration of our imaging technologies into their research workflows.